(5R)-5-Hydroxytriptolide (LLDT-8) Ameliorates Experimental Autoimmune Myositis via Suppression of the NLRC5/MHC-I Signaling PathwayTingting Hao, Jianping Zuo|Pharmaceuticals|2026Cited by 0